Literature DB >> 27417072

Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients.

Pantelis Maiovis1, Panagiotis Ioannidis1, Georgios Gerasimou1, Anna Gotzamani-Psarrakou1, Dimitrios Karacostas1.   

Abstract

Severity assessment scales for frontotemporal lobar degeneration (FTLD) have been recently introduced. In the present study, the authors examined whether the FTLD-modified Clinical Dementia Rating (FTLD-CDR) scale and the Frontotemporal Dementia Rating Scale (FRS) correlated with regional brain perfusion in Greek FTLD patients. A total of 47 behavioral variant frontotemporal dementia (bvFTD) patients and 33 primary progressive aphasia (PPA) patients were assessed for demographic data, cognitive reserve (CR), and severity of dementia and underwent brain single-photon emission computed tomography. Both scales were valid in the bvFTD group, predicting frontal lobe perfusion. In the PPA group, both scales were found to predict temporal hypoperfusion only after accounting for CR, which could imply a potential role for reserve in PPA patients.

Entities:  

Mesh:

Year:  2016        PMID: 27417072     DOI: 10.1176/appi.neuropsych.16020034

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  2 in total

1.  Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.

Authors:  Toji Miyagawa; Danielle Brushaber; Jeremy Syrjanen; Walter Kremers; Julie Fields; Leah K Forsberg; Hilary W Heuer; David Knopman; John Kornak; Adam Boxer; Howie Rosen; Bradley Boeve
Journal:  Alzheimers Dement       Date:  2020-01-06       Impact factor: 21.566

2.  Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages.

Authors:  Ray-Chang Tzeng; Yu-Wan Yang; Kai-Cheng Hsu; Hsin-Te Chang; Pai-Yi Chiu
Journal:  Front Aging Neurosci       Date:  2022-09-23       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.